pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

MIT reports 20% drop in graduate enrollment after $100 million federal research cut, warning of basic-research drought

Oct 14, 2026·read at STAT ↗RegulatoryNegative

MIT President Sally Kornbluth told the STAT Summit that the university saw a 20% decline in new graduate students this fall, linked to a $100 million reduction in federal research awards over the past two years.

The funding cut has forced MIT and other universities to limit or suspend graduate admissions, as many students rely on federal grants to support their Ph.D. work.

Science leaders warned that shifting federal research dollars toward artificial intelligence and other technology areas could create a serious drought in curiosity-driven basic research.

They urged policymakers to consider the long-term impact on the nation’s research pipeline and the training of future scientists.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university”

read at STAT ↗
1,516 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGNational Institutes of HealthRISING
topics
CRISPR/Cas92Infectious DiseaseOphthalmology

related stories

  • Jul 28STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDSTAT
  • Sep 15Businesses can now apply for NIH fundingSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 11Opinion: How long Covid’s scientific stalemate made it politically erasableSTAT
  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace